| 臺大學術典藏 |
2020-08-12T02:50:46Z |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
|
Shih J.-Y.; CHAO-CHI HO; Yu K.-L.; Chen L.-Y.;Molina-Vila M.A.;Ruan S.-Y.;Su K.-Y.;Liao W.-Y.;Yu K.-L.;Chao-Chi Ho;Shih J.-Y.;Yu C.-J.;Yang J.C.H.;Rosell R.;Yang P.-C.; Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; Liao W.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T02:50:41Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Chao-Chi Ho;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; CHAO-CHI HO; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2020-08-12T02:50:40Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.;Shih J.-Y.;Yu C.-J.;Chao-Chi Ho;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Su K.-Y.;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; CHAO-CHI HO; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-08-12T02:50:36Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Wu C.-T.; Chang Y.-L.; Yang C.-Y.;Liao W.-Y.;Chao-Chi Ho;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y. |
| 臺大學術典藏 |
2020-08-12T02:50:35Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.;Liao W.-Y.;Chao-Chi Ho;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:27Z |
Identification of Five Driver Gene Mutations in Patients with Treatment-Na?ve Lung Adenocarcinoma in Taiwan
|
Hsu K.-H.; CHAO-CHI HO; Hsia T.-C.; Tseng J.-S.; Su K.-Y.; Wu M.-F.; Chiu K.-L.; Yang T.-Y.; Chen K.-C.; Ooi H.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; Liao W.-Y.; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Yang P.-C.; Chang G.-C. |
| 臺大學術典藏 |
2020-07-21T06:46:26Z |
EGFR mutation and lobar location of lung adenocarcinoma
|
Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; CHAO-CHI HO; Hsia T.-C.; Su K.-Y.; Wu M.-F.; Chiu K.-L.; Liu C.-M.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; Liao W.-Y.; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Yang P.-C.; Yang T.-Y.; Chang G.-C. |
| 臺大學術典藏 |
2020-07-21T06:46:25Z |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
|
Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; Liao W.-Y.; Yu K.-L.; CHAO-CHI HO; Shih J.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C. |
| 臺大學術典藏 |
2020-07-21T06:46:24Z |
EGFR mutation, smoking, and gender in advanced lung adenocarcinoma
|
Tseng C.-H.; Chiang C.-J.; Tseng J.-S.; Yang T.-Y.; Hsu K.-H.; Chen K.-C.; Wang C.-L.; Chen C.-Y.; Yen S.H.; Tsai C.-M.; Huang M.-S.; CHAO-CHI HO; Yu C.-J.; Tsai Y.-H.; Chen J.-S.; Chou T.-Y.; Tsai M.-H.; Chen H.-Y.; Su K.-Y.; Chen J.J.W.; Chen H.-W.; Yu S.-L.; Liu T.-W.; Chang G.-C. |
| 臺大學術典藏 |
2020-07-21T06:46:24Z |
Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients
|
Chen J.J.W.; Chang G.-C.; Yang P.-C.; Liu C.-M.; Chiu K.-L.; Wu M.-F.; Hsia T.-C.; CHAO-CHI HO; Yu C.-J.; Tseng C.-H.; Chen H.-Y.; Chen K.-C.; Tsai C.-R.; Yang C.-T.; Yu S.-L.; Su K.-Y.; Yang T.-Y.; Wang C.-L.; Hsu K.-H.; Tseng J.-S. |
| 臺大學術典藏 |
2020-07-21T06:46:21Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin C.-C.; Lee J.-H.; Chang Y.-L.; Su K.-Y.; Hsu W.-H.; Hsu C.-L.; Tsai T.-H.; Chen K.-Y.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; CHAO-CHI HO; Liao W.-Y.; Yu C.-J.; Yang J.C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:46:19Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Yu C.-J.; CHAO-CHI HO; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.; Lin C.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:46:15Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Chang Y.-L.; Su K.-Y.; Hsu C.-L.; Liu Y.-N.; Chen K.-Y.; Tsai T.-H.; Liao W.-Y.; CHAO-CHI HO; Yang C.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:19Z |
RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer
|
TZU-HSIU TSAI; Su K.-Y.; Wu S.-G.; Chang Y.-L.; Luo S.-C.; Jane I.-S.; Yu C.-J.; Yue S.-L.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-07-21T06:25:17Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Yang J.C.-H.; Thress K.S.; Huang D.D.-R.; Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tzu-Hsiu Tsai;Su K.-Y.;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; TZU-HSIU TSAI; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:17Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Liao W.-Y.; Ho C.-C.; Liao B.-C.; Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tzu-Hsiu Tsai;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Yang J.C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Lee J.-H.; Chang Y.-L.; Su K.-Y.; Hsu W.-H.; Hsu C.-L.; TZU-HSIU TSAI; Chen K.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:11Z |
EGFR mutation and lobar location of lung adenocarcinoma
|
Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; WEI-YU LIAO; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Yang P.-C.; Yang T.-Y.; Chang G.-C.; Chen H.-J.; Wu T.-C.; Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Ho C.-C.; Hsia T.-C.; Su K.-Y.; Wu M.-F.; Chiu K.-L.; Liu C.-M. |
| 臺大學術典藏 |
2020-07-21T06:09:10Z |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
|
Chen L.-Y.;Molina-Vila M.A.;Ruan S.-Y.;Su K.-Y.;Wei-Yu Liao;Yu K.-L.;Ho C.-C.;Shih J.-Y.;Yu C.-J.;Yang J.C.H.;Rosell R.;Yang P.-C.; Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; WEI-YU LIAO; Yu K.-L.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C. |
| 臺大學術典藏 |
2020-07-21T06:09:08Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Wei-Yu Liao;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; WEI-YU LIAO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:09:03Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Chen K.-Y.; Tsai T.-H.; Ho C.-C.; WEI-YU LIAO; Yang C.-Y.; Yang C.-Y.;Wei-Yu Liao;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yu C.-J.; Yang J.C.-H.; Shih J.-Y.; Lin C.-C.; Lee J.-H.; Hsu W.-H.; Liao B.-C.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C. |
| 臺大學術典藏 |
2020-07-21T05:40:29Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Lee J.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Ching-Yao Yang;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; CHING-YAO YANG; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H. |
| 臺大學術典藏 |
2020-07-03T02:18:23Z |
Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E
|
Yan B.-S.; Hong Q.-S.; Singh S.; CHUAN-LIANG KAO; Chen H.-Y.; Su K.-Y.; Li K.-C.; Cheng C.-L.; Cheng H.-W.; Lee J.-Y.; Lee C.-N.; Yang P.-C.; Chang S.-Y.; Chen J.J.W.; Ho B.-C. ;Yu S.-L. ;Chen J.J.W. ;Chang S.-Y. ;Yan B.-S. ;Hong Q.-S. ;Singh S. ;Chuan-Liang Kao ;Chen H.-Y. ;Su K.-Y. ;Li K.-C. ;Cheng C.-L. ;Cheng H.-W. ;Lee J.-Y. ;Lee C.-N. ;Yang P.-C.; Ho B.-C.; Yu S.-L. |
| 臺大學術典藏 |
2020-07-01T07:39:37Z |
Proofreading and DNA repair assay using single nucleotide extension and MALDI-TOF mass spectrometry analysis
|
Su K.-Y.;Goodman S.D.;Lai H.-M.;Yen R.-S.;Hu W.-Y.;Cheng W.-C.;Lin L.-I.;Yang Y.-C.;Woei-Horng Fang; Su K.-Y.; Goodman S.D.; Lai H.-M.; Yen R.-S.; Hu W.-Y.; Cheng W.-C.; Lin L.-I.; Yang Y.-C.; WOEI-HORNG FANG |
| 臺大學術典藏 |
2020-07-01T07:39:37Z |
DNA polymerase I proofreading exonuclease activity is required for endonuclease V repair pathway both in vitro and in vivo
|
Su K.-Y.;Lin L.-I.;Goodman S.D.;Yen R.-S.;Wu C.-Y.;Chang W.-C.;Yang Y.-C.;Cheng W.-C.;Woei-Horng Fang; Su K.-Y.; Lin L.-I.; Goodman S.D.; Yen R.-S.; Wu C.-Y.; Chang W.-C.; Yang Y.-C.; Cheng W.-C.; WOEI-HORNG FANG |
| 臺大學術典藏 |
2020-07-01T07:39:37Z |
Application of single nucleotide extension and MALDI-TOF mass spectrometry in proofreading and DNA repair assay
|
Su K.-Y.;Lai H.-M.;Goodman S.D.;Hu W.-Y.;Cheng W.-C.;Lin L.-I.;Yang Y.-C.;Woei-Horng Fang; Su K.-Y.; Lai H.-M.; Goodman S.D.; Hu W.-Y.; Cheng W.-C.; Lin L.-I.; Yang Y.-C.; WOEI-HORNG FANG |
| 臺大學術典藏 |
2020-07-01T07:39:36Z |
Novel therapeutic drug identification and gene correlation for fatty liver disease using high-content screening: Proof of concept
|
Luo W.-J.;Cheng T.-Y.;Wong K.-I.;Woei-Horng Fang;Liao K.-M.;Hsieh Y.-T.;Su K.-Y.; Luo W.-J.; Cheng T.-Y.; Wong K.-I.; WOEI-HORNG FANG; Liao K.-M.; Hsieh Y.-T.; Su K.-Y. |
| 臺大學術典藏 |
2020-07-01T07:39:36Z |
Proofreading of single nucleotide insertion/deletion replication errors analyzed by MALDI-TOF mass spectrometry assay
|
Chang H.-L.;Su K.-Y.;Goodman S.D.;Chou N.-A.;Lin K.-C.;Cheng W.-C.;Lin L.-I.;Chang S.-Y.;Woei-Horng Fang; Chang H.-L.; Su K.-Y.; Goodman S.D.; Chou N.-A.; Lin K.-C.; Cheng W.-C.; Lin L.-I.; Chang S.-Y.; WOEI-HORNG FANG |
| 臺大學術典藏 |
2020-06-22T07:37:15Z |
Mice deficient in collapsin response mediator protein-1 exhibit impaired long-term potentiation and impaired spatial learning and memory
|
Su K.-Y.;Chien W.-L.;Fu W.-M.;Yu I.-S.;Huang H.-P.;Huang P.-H.;Lin S.-R.;Shih J.-Y.;Lin Y.-L.;Hsueh Y.-P.;Yang P.-C.;Shu-Wha Lin; Su K.-Y.; Chien W.-L.; Fu W.-M.; Yu I.-S.; Huang H.-P.; Huang P.-H.; Lin S.-R.; Shih J.-Y.; Lin Y.-L.; Hsueh Y.-P.; Yang P.-C.; SHU-WHA LIN |
| 臺大學術典藏 |
2020-06-22T07:37:15Z |
Decreased expressions of hepsin in human hepatocellular carcinomas
|
Chen C.-H.;Su K.-Y.;Tao M.-H.;Shu-Wha Lin;Su Y.-H.;Tsai Y.-C.;Cheng K.-C.;Jeng Y.-M.;Sheu J.-C.; Chen C.-H.; Su K.-Y.; Tao M.-H.; SHU-WHA LIN; Su Y.-H.; Tsai Y.-C.; Cheng K.-C.; Jeng Y.-M.; Sheu J.-C. |
| 臺大學術典藏 |
2020-06-19T02:38:32Z |
Application of single nucleotide extension and MALDI-TOF mass spectrometry in proofreading and DNA repair assay
|
Su K.-Y.;Lai H.-M.;Goodman S.D.;Hu W.-Y.;Cheng W.-C.;Lin L.-I.;Ya-Chien Yang;Fang W.-H.; Su K.-Y.; Lai H.-M.; Goodman S.D.; Hu W.-Y.; Cheng W.-C.; Lin L.-I.; YA-CHIEN YANG; Fang W.-H. |
| 臺大學術典藏 |
2020-06-19T02:38:31Z |
Proofreading and DNA repair assay using single nucleotide extension and MALDI-TOF mass spectrometry analysis
|
Su K.-Y.; Goodman S.D.; Lai H.-M.; Yen R.-S.; Hu W.-Y.; Cheng W.-C.; Lin L.-I.; YA-CHIEN YANG; Fang W.-H.; Su K.-Y.;Goodman S.D.;Lai H.-M.;Yen R.-S.;Hu W.-Y.;Cheng W.-C.;Lin L.-I.;Ya-Chien Yang;Fang W.-H. |
| 臺大學術典藏 |
2020-06-19T02:38:31Z |
DNA polymerase I proofreading exonuclease activity is required for endonuclease V repair pathway both in vitro and in vivo
|
Su K.-Y.;Lin L.-I.;Goodman S.D.;Yen R.-S.;Wu C.-Y.;Chang W.-C.;Ya-Chien Yang;Cheng W.-C.;Fang W.-H.; Su K.-Y.; Lin L.-I.; Goodman S.D.; Yen R.-S.; Wu C.-Y.; Chang W.-C.; YA-CHIEN YANG; Cheng W.-C.; Fang W.-H. |
| 臺大學術典藏 |
2020-06-18T08:26:13Z |
Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E
|
Ho B.-C.;Yu S.-L.;Chen J.J.W.;Sui-Yuan Chang;Yan B.-S.;Hong Q.-S.;Singh S.;Kao C.-L.;Chen H.-Y.;Su K.-Y.;Li K.-C.;Cheng C.-L.;Cheng H.-W.;Lee J.-Y.;Lee C.-N.;Yang P.-C.; Ho B.-C.; Yu S.-L.; Chen J.J.W.; SUI-YUAN CHANG; Yan B.-S.; Hong Q.-S.; Singh S.; Kao C.-L.; Chen H.-Y.; Su K.-Y.; Li K.-C.; Cheng C.-L.; Cheng H.-W.; Lee J.-Y.; Lee C.-N.; Yang P.-C. |
| 臺大學術典藏 |
2020-06-18T08:25:49Z |
Proofreading of single nucleotide insertion/deletion replication errors analyzed by MALDI-TOF mass spectrometry assay
|
Chang H.-L.;Su K.-Y.;Goodman S.D.;Chou N.-A.;Lin K.-C.;Cheng W.-C.;Lin L.-I.;Sui-Yuan Chang;Fang W.-H.; Chang H.-L.; Su K.-Y.; Goodman S.D.; Chou N.-A.; Lin K.-C.; Cheng W.-C.; Lin L.-I.; SUI-YUAN CHANG; Fang W.-H. |
| 臺大學術典藏 |
2020-06-17T03:01:52Z |
Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E
|
Ho B.-C. ;Sung-Liang Yu ;Chen J.J.W. ;Chang S.-Y. ;Yan B.-S. ;Hong Q.-S. ;Singh S. ;Kao C.-L. ;Chen H.-Y. ;Su K.-Y. ;Li K.-C. ;Cheng C.-L. ;Cheng H.-W. ;Lee J.-Y. ;Lee C.-N. ;Yang P.-C.; Ho B.-C.; SUNG-LIANG YU; Chen J.J.W.; Chang S.-Y.; Yan B.-S.; Hong Q.-S.; Singh S.; Kao C.-L.; Chen H.-Y.; Su K.-Y.; Li K.-C.; Cheng C.-L.; Cheng H.-W.; Lee J.-Y.; Lee C.-N.; Yang P.-C. |
| 臺大學術典藏 |
2020-06-17T03:01:51Z |
Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor
|
Chang T.-H. ;Tsai M.-F. ;Su K.-Y. ;Wu S.-G. ;Huang C.-P. ;Sung-Liang Yu ;Yu Y.-L. ;Lan C.-C. ;Yang C.-H. ;Lin S.-B. ;Wu C.-P. ;Shih J.-Y. ;Yang P.-C.; Chang T.-H.; Tsai M.-F.; Su K.-Y.; Wu S.-G.; Huang C.-P.; SUNG-LIANG YU; Yu Y.-L.; Lan C.-C.; Yang C.-H.; Lin S.-B.; Wu C.-P.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-06-17T03:01:49Z |
Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations
|
Yuan S. ;Sung-Liang Yu ;Chen H.-Y. ;Hsu Y.-C. ;Su K.-Y. ;Chen H.-W. ;Chen C.-Y. ;Yu C.-J. ;Shih J.-Y. ;Chang Y.-L. ;Cheng C.-L. ;Hsu C.-P. ;Hsia J.-Y. ;Lin C.-Y. ;Wu G. ;Liu C.-H. ;Wang C.-D. ;Yang K.-C. ;Chen Y.-W. ;Lai Y.-L. ;Hsu C.-C. ;Lin T.-C. ;Yang T.-Y. ;Chen K.-C. ;Hsu K.-H. ;Chen J.J.W. ;Chang G.-C. ;Li K.-C. ;Yang P.-C.; Yuan S.; SUNG-LIANG YU; Chen H.-Y.; Hsu Y.-C.; Su K.-Y.; Chen H.-W.; Chen C.-Y.; Yu C.-J.; Shih J.-Y.; Chang Y.-L.; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C. |
| 臺大學術典藏 |
2020-06-17T03:01:41Z |
Impact of EGFR mutation detection methods on the efficacy of erlotinib in patients with advanced EGFR-wild type lung adenocarcinoma
|
Tseng J.-S.;Wang C.-L.;Huang M.-S.;Chen C.-Y.;Chang C.-Y.;Yang T.-Y.;Tsai C.-R.;Chen K.-C.;Hsu K.-H.;Tsai M.-H.;Sung-Liang Yu;Su K.-Y.;Wu C.-W.;Yang C.-T.;Chen Y.-M.;Chang G.-C.; Tseng J.-S.; Wang C.-L.; Huang M.-S.; Chen C.-Y.; Chang C.-Y.; Yang T.-Y.; Tsai C.-R.; Chen K.-C.; Hsu K.-H.; Tsai M.-H.; SUNG-LIANG YU; Su K.-Y.; Wu C.-W.; Yang C.-T.; Chen Y.-M.; Chang G.-C. |
| 臺大學術典藏 |
2020-06-17T03:01:38Z |
R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability
|
Chen H.-Y.;Sung-Liang Yu;Ho B.-C.;Su K.-Y.;Hsu Y.-C.;Chang C.-S.;Li Y.-C.;Yang S.-Y.;Hsu P.-Y.;Ho H.;Chang Y.-H.;Chen C.-Y.;Yang H.-I.;Hsu C.-P.;Yang T.-Y.;Chen K.-C.;Hsu K.-H.;Tseng J.-S.;Hsia J.-Y.;Chuang C.-Y.;Yuan S.;Lee M.-H.;Liu C.-H.;Wu G.-I.;Hsiung C.A.;Chen Y.-M.;Wang C.-L.;Huang M.-S.;Yu C.-J.;Chen K.-Y.;Tsai Y.-H.;Su W.-C.;Chen H.-W.;Chen J.J.W.;Chen C.-J.;Chang G.-C.;Yang P.-C.;Li K.-C.; Chen H.-Y.; SUNG-LIANG YU; Ho B.-C.; Su K.-Y.; Hsu Y.-C.; Chang C.-S.; Li Y.-C.; Yang S.-Y.; Hsu P.-Y.; Ho H.; Chang Y.-H.; Chen C.-Y.; Yang H.-I.; Hsu C.-P.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Hsia J.-Y.; Chuang C.-Y.; Yuan S.; Lee M.-H.; Liu C.-H.; Wu G.-I.; Hsiung C.A.; Chen Y.-M.; Wang C.-L.; Huang M.-S.; Yu C.-J.; Chen K.-Y.; Tsai Y.-H.; Su W.-C.; Chen H.-W.; Chen J.J.W.; Chen C.-J.; Chang G.-C.; Yang P.-C.; Li K.-C. |
| 臺大學術典藏 |
2020-06-17T03:01:34Z |
JAG1 is associated with poor survival through inducing metastasis in lung cancer
|
Chang W.-H.;Ho B.-C.;Hsiao Y.-J.;Chen J.-S.;Yeh C.-H.;Chen H.-Y.;Chang G.-C.;Su K.-Y.;Sung-Liang Yu; Chang W.-H.; Ho B.-C.; Hsiao Y.-J.; Chen J.-S.; Yeh C.-H.; Chen H.-Y.; Chang G.-C.; Su K.-Y.; SUNG-LIANG YU |
| 臺大學術典藏 |
2020-06-17T03:01:32Z |
Rapid Sputum Multiplex Detection of the M. tuberculosis Complex (MTBC) and Resistance Mutations for Eight Antibiotics by Nucleotide MALDI-TOF MS
|
Su K.-Y.;Yan B.-S.;Chiu H.-C.;Yu C.-J.;Chang S.-Y.;Jou R.;Liu J.-L.;Hsueh P.-R.;Sung-Liang Yu; Su K.-Y.; Yan B.-S.; Chiu H.-C.; Yu C.-J.; Chang S.-Y.; Jou R.; Liu J.-L.; Hsueh P.-R.; SUNG-LIANG YU |
| 臺大學術典藏 |
2020-06-17T03:01:32Z |
EGFR mutation, smoking, and gender in advanced lung adenocarcinoma
|
Chen K.-C.; Wang C.-L.; Chen C.-Y.; Yen S.H.; Tsai C.-M.; Huang M.-S.; Ho C.-C.; Yu C.-J.; Tsai Y.-H.; Chen J.-S.; Chou T.-Y.; Tsai M.-H.; Chen H.-Y.; Su K.-Y.; Chen J.J.W.; Chen H.-W.; SUNG-LIANG YU; Liu T.-W.; Chang G.-C.; Tseng C.-H.;Chiang C.-J.;Tseng J.-S.;Yang T.-Y.;Hsu K.-H.;Chen K.-C.;Wang C.-L.;Chen C.-Y.;Yen S.H.;Tsai C.-M.;Huang M.-S.;Ho C.-C.;Yu C.-J.;Tsai Y.-H.;Chen J.-S.;Chou T.-Y.;Tsai M.-H.;Chen H.-Y.;Su K.-Y.;Chen J.J.W.;Chen H.-W.;Sung-Liang Yu;Liu T.-W.;Chang G.-C.; Tseng C.-H.; Chiang C.-J.; Tseng J.-S.; Yang T.-Y.; Hsu K.-H. |
| 臺大學術典藏 |
2020-06-17T03:01:31Z |
Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non–small cell lung cancer patients
|
Pan S.-H.;Su K.-Y.;Spiessens B.;Kusuma N.;Delahaye N.F.;Gruselle O.;Myo A.;De Creus A.;Louahed J.;Chang G.-C.;Sung-Liang Yu;Yang P.-C.; Pan S.-H.; Su K.-Y.; Spiessens B.; Kusuma N.; Delahaye N.F.; Gruselle O.; Myo A.; de Creus A.; Louahed J.; Chang G.-C.; SUNG-LIANG YU; Yang P.-C. |
| 臺大學術典藏 |
2020-06-17T03:01:30Z |
The association of acquired T790M mutation with clinical characteristics after resistance to first-line epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma
|
Huang Y.-H.;Hsu K.-H.;Tseng J.-S.;Chen K.-C.;Hsu C.-H.;Su K.-Y.;Chen J.J.W.;Chen H.-W.;Sung-Liang Yu;Yang T.-Y.;Chang G.-C.; Huang Y.-H.; Hsu K.-H.; Tseng J.-S.; Chen K.-C.; Hsu C.-H.; Su K.-Y.; Chen J.J.W.; Chen H.-W.; SUNG-LIANG YU; Yang T.-Y.; Chang G.-C. |
| 臺大學術典藏 |
2020-06-17T03:01:30Z |
FAM198B is associated with prolonged survival and inhibits metastasis in lung adenocarcinoma via blockage of ERK-Mediated MMP-1 expression
|
Hsu C.-Y.;Chang G.-C.;Chen Y.-J.;Hsu Y.-C.;Hsiao Y.-J.;Su K.-Y.;Chen H.-Y.;Lin C.-Y.;Chen J.-S.;Chen Y.-J.;Hong Q.-S.;Ku W.-H.;Wu C.-Y.;Ho B.-C.;Chiang C.-C.;Yang P.-C.;Sung-Liang Yu; Hsu C.-Y.; Chang G.-C.; Chen Y.-J.; Hsu Y.-C.; Hsiao Y.-J.; Su K.-Y.; Chen H.-Y.; Lin C.-Y.; Chen J.-S.; Chen Y.-J.; Hong Q.-S.; Ku W.-H.; Wu C.-Y.; Ho B.-C.; Chiang C.-C.; Yang P.-C.; SUNG-LIANG YU |
| 臺大學術典藏 |
2020-06-17T03:01:30Z |
Characteristics and Predictive Value of PD-L1 Status in Real-World NonSmall Cell Lung Cancer Patients
|
Tseng J.-S.;Yang T.-Y.;Wu C.-Y.;Ku W.-H.;Chen K.-C.;Hsu K.-H.;Huang Y.-H.;Su K.-Y.;Sung-Liang Yu;Chang G.-C.; Tseng J.-S.; Yang T.-Y.; Wu C.-Y.; Ku W.-H.; Chen K.-C.; Hsu K.-H.; Huang Y.-H.; Su K.-Y.; SUNG-LIANG YU; Chang G.-C. |
| 臺大學術典藏 |
2020-06-17T03:01:29Z |
Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma
|
Su K.-Y.;Tseng J.-S.;Liao K.-M.;Yang T.-Y.;Chen K.-C.;Hsu K.-H.;Yang P.-C.;Sung-Liang Yu;Chang G.-C.; Su K.-Y.; Tseng J.-S.; Liao K.-M.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Yang P.-C.; SUNG-LIANG YU; Chang G.-C. |
| 臺大學術典藏 |
2020-06-17T03:01:29Z |
Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer
|
Lin M.-W.;Su K.-Y.;Su T.-J.;Chang C.-C.;Lin J.-W.;Lee Y.-H.;Sung-Liang Yu;Chen J.-S.;Hsieh M.-S.; Lin M.-W.; Su K.-Y.; Su T.-J.; Chang C.-C.; Lin J.-W.; Lee Y.-H.; SUNG-LIANG YU; Chen J.-S.; Hsieh M.-S. |
| 臺大學術典藏 |
2020-06-17T03:01:29Z |
Intercalated treatment following rebiopsy is associated with a shorter progression-free survival of osimertinib treatment
|
Tseng J.-S.;Yang T.-Y.;Chen K.-C.;Hsu K.-H.;Huang Y.-H.;Su K.-Y.;Sung-Liang Yu;Chang G.-C.; Tseng J.-S.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Huang Y.-H.; Su K.-Y.; SUNG-LIANG YU; Chang G.-C. |
| 臺大學術典藏 |
2020-06-17T03:01:29Z |
High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment na?ve advanced EGFR-mutant lung adenocarcinoma patients
|
Hsu K.-H.;Huang Y.-H.;Tseng J.-S.;Chen K.-C.;Ku W.-H.;Su K.-Y.;Chen J.J.W.;Chen H.-W.;Sung-Liang Yu;Yang T.-Y.;Chang G.-C.; Hsu K.-H.; Huang Y.-H.; Tseng J.-S.; Chen K.-C.; Ku W.-H.; Su K.-Y.; Chen J.J.W.; Chen H.-W.; SUNG-LIANG YU; Yang T.-Y.; Chang G.-C. |
